TORONTO, June 11 /CNW/ - Amorfix Life Sciences (TSX-V:AMF), a company
focused on diagnostics and treatments for brain wasting diseases, today
announced its operational and financial results for the year ended March 31,
2007, as well as financial results for the fourth quarter.
